about
A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonismEmerging from the bottleneck: benefits of the comparative approach to modern neuroscienceThe potential roles of T-type Ca2+ channels in motor coordination.Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties.Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's DiseaseDeep brain stimulation-associated brain tissue imprints: a new in vivo approach to biological research in human Parkinson's diseaseUtilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals.Radioiodine-induced kidney damage and protective effect of amifostine: An experimental study.A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's ResearchZonisamide: a review of the clinical and experimental evidence for its use in Parkinson's diseaseAdvances in non-dopaminergic treatments for Parkinson's diseaseMimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.Neuroprotective Surgical Strategies in Parkinson's Disease: Role of Preclinical Data.The emperor's new wardrobe: Rebalancing diversity of animal models in neuroscience research.Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease.6-OHDA-Lesioned Adult Zebrafish as a Useful Parkinson's Disease Model for Dopaminergic Neuroregeneration.Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age.Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara.Reprogramming of Human Huntington Fibroblasts Using mRNA
P2860
Q21560999-0026F2D3-74C4-4747-BA50-CE9624458D0CQ28083884-BE66617C-C7D4-40ED-87AB-1AB23191ED24Q30447586-BBEA7833-F84D-427E-AF2E-24496585B566Q34230271-6F1DFE57-14CC-4277-80C8-7826E7415CF2Q35623461-0675466B-18FC-4FB6-8422-BFED12B27BF0Q35922870-F5983C30-E403-4C76-82F3-17D075F1133BQ35971342-760FB430-BAD3-4A8D-87B4-DFE85501044AQ36494212-3D0E6EF7-2DBE-4210-915F-F2C6B7769FC5Q36513900-F2D98FB0-263A-4CEB-A20B-10209AB148CBQ36826631-4A038FE0-6144-4DDA-94E5-3BC651F8D54EQ37082662-AF06FD6C-2D86-4C5B-B190-4DFF2F23337BQ37287403-B1D4089E-B9CB-4AB4-90F4-BAF136C95A10Q37356891-52997093-4CEB-435A-9749-3E3F202C5E76Q38218083-5AF13962-BA3D-4204-806E-7FD397664854Q39443289-C6BDF4BC-5FA6-4B8F-83CA-F2D57BBD32A0Q44266420-EE609EE4-7571-452D-B16A-09AF2CC63699Q46273765-35A327C1-BA15-4325-9695-DD6FA83DDE88Q47914237-49B53CC2-1C3A-4944-A96E-D1EE4F4FD6DAQ48196426-52E0CE9E-DD3D-48C2-8BA1-ED57EBFF8D8FQ55119787-FF5D197B-FDD1-498E-8CF2-278A3FB35BE9Q55709567-C1657475-5C44-4800-876B-4C7FD01AEA58Q58689779-38FF75C8-F7E3-4D69-B543-94721C5F8CD6
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Limitations of animal models of Parkinson's disease.
@en
type
label
Limitations of animal models of Parkinson's disease.
@en
prefLabel
Limitations of animal models of Parkinson's disease.
@en
P2093
P2860
P356
P1433
P1476
Limitations of animal models of Parkinson's disease.
@en
P2093
J A Potashkin
N K Runkle
P2860
P304
P356
10.4061/2011/658083
P577
2010-12-20T00:00:00Z